Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Norwegian Dry Eye Clinic (Tørrklinikken) is a specialized medical facility based in Oslo, Norway, dedicated to the advanced diagnosis and treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD). The clinic employs a comprehensive diagnostic approach using technologies such as meibography, interferometry, and tear osmolarity testing to tailor treatments to individual patient needs. Their therapeutic portfolio includes cutting-edge non-pharmacological interventions such as Intense Pulsed Light (IPL) therapy, Rexon-Eye (Quantum Molecular Resonance technology), and LipiFlow thermal pulsation. As a leading center for ocular surface disorders in Scandinavia, the clinic also participates in clinical research and professional education for ophthalmologists and optometrists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norwegian Dry Eye Clinic.